View Older Stories View More Recent Stories

Jul 2, 2019 09:25AM Applied DNA Signs 5-Year Agreement with Iconic Writing Instrument Specialist Montblanc-Simplo GMBH to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients
Jul 1, 2019 09:25AM LineaRx Receives Multiple Purchase Orders for Linear DNA for Use in Therapeutic Development
Jun 26, 2019 09:15AM LineaRx Ships DNA to Support Therapy Development for Neurodegenerative Diseases
Jun 24, 2019 08:05AM TheraCann Adds Blockchain Functionality to ETCH biotrace Platform Powered by Applied DNA 
Jun 14, 2019 08:00AM Molecular Tagging of Pharmaceutical Drugs Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal
Jun 10, 2019 08:00AM Applied DNA Cannabis Partner TheraCann International Secures Agreement with South Africa’s House of Hemp
May 30, 2019 08:00AM Applied DNA Closes the Loop on Traceability for Egyptian Pima with Genotyping Assays for Cotton Authentication
May 15, 2019 08:04AM TheraCann and CannAcubed Enter Collaboration Agreement to Validate Cannabis and Hemp Supply Chain in China
May 10, 2019 05:00AM Applied DNA to Webcast 2019 Annual Stockholders’ Meeting
May 9, 2019 04:05PM Applied DNA Reports Fiscal Second Quarter 2019 Financial Results
May 8, 2019 08:30AM A&E to Preview ‘Integrity’ Molecular-Tagged Thread Solution From Applied DNA Sciences at Texprocess
May 2, 2019 05:30AM Applied DNA’s Molecular Tagging Technology to Ensure Authenticity of Egyptian Cotton
May 2, 2019 04:00AM Applied DNA Schedules Fiscal 2019 Second Quarter Financial Results Conference Call for Thursday, May 9, 2019 at 4:30 PM ET
Apr 29, 2019 09:16AM Applied DNA Sciences (APDN) Announces LineaRx Achieves Higher Expression, Survival Rates in Human T Cells Transfected Non-Virally with Linear DNA
Apr 29, 2019 09:15AM LineaRx Achieves Higher Expression and Survival Rates in Human T Cells Transfected Non-Virally with Linear DNA
Apr 24, 2019 01:00PM Applied DNA Receives Initial $1 Million Payment from TheraCann International
Apr 22, 2019 02:09PM Applied DNA and GHCL Launch “REKOOP” Verified by the CertainT Platform on Amazon.com on Earth Day
Apr 12, 2019 03:00AM Applied DNA Signs Memorandum of Understanding with Process Chemicals Leader Stahl to Bring CertainT® Platform to Manufacturing Supply Chains
Apr 8, 2019 08:00AM Applied DNA Subsidiary LineaRx Achieves Biotech Industry First with Anti-CD19 Expression in Human CAR T Cells via Proprietary Non-Viral, Plasmid-Free Platform
Apr 3, 2019 02:05PM Applied DNA’s Platform Empowers President Trump’s Anti-Counterfeiting Memorandum Signed Today to Protect American Consumers and Industries
Apr 2, 2019 08:45AM Loftex Sets New Standard in Sustainability Utilizing CertainT
Mar 29, 2019 06:02AM Applied DNA Sciences (APDN) Reports Exclusive Cannabis Licensing and Cooperation Agreement with Theracann International
Mar 29, 2019 05:30AM Applied DNA Announces Exclusive Cannabis Licensing and Cooperation Agreement with Theracann International
Mar 1, 2019 05:00AM Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
Feb 12, 2019 05:52AM Applied DNA Sciences (APDN) Announces Long-Term Licensing Agreement with TheraCann International for CertainT Platform in Legal Cannabis and Hemp
Feb 12, 2019 05:00AM Applied DNA Signs Term Sheet with TheraCann International for Exclusive License of CertainT® Platform in Legal Cannabis and Hemp
Feb 7, 2019 04:05PM Applied DNA Reports Fiscal First Quarter 2019 Financial Results
Feb 6, 2019 03:51PM Applied DNA Sciences (APDN) says two prior announcements by Israel Cannabis raise opportunity for uptake of its CertainT Cannabis Tagging platform
Feb 6, 2019 03:46PM Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis (iCAN)
Jan 31, 2019 05:00AM Applied DNA Schedules Fiscal 2019 First Quarter Financial Results Conference Call for Thursday, February 7, 2019 at 4:30 PM ET
Jan 29, 2019 05:00AM Applied DNA Appoints Stephen Birkhold to the Strategic Advisory Board
Jan 28, 2019 05:00AM Applied DNA Signs MOU with Tex-Ray Industrial to Introduce CertainT® Authentication Platform to Global Textile Brands
Jan 24, 2019 05:00AM Applied DNA Signs Memorandum of Understanding with Sun Chemical Supply Company to Bring CertainT® Authentication Platform to Textile Manufacturers in Asia
Dec 19, 2018 04:08PM Applied DNA Sciences (APDN) Plans Public Offering of Common Stock and Warrants
Dec 19, 2018 04:06PM Applied DNA Announces Proposed Public Offering of Common Stock and Warrants
Dec 13, 2018 07:00AM Applied DNA Announces Selected Preliminary Unaudited Fiscal 2018 Year End and Fourth Quarter Financial Results
Dec 10, 2018 05:00AM Applied DNA Signs Joint Development Agreement with Everledger to Develop and Market a CertainT®-Enhanced, Blockchain-Based Platform for Provenance Verification
Dec 6, 2018 08:30AM Applied DNA to Participate at Cannabis Capital Forum on December 7
Dec 4, 2018 12:28PM LineaRx to Hold Analyst Day Webinar to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
Nov 26, 2018 05:00AM Applied DNA’s SigNature® DNA Evidence Helps to Convict Over 131 Criminals to Date
Nov 19, 2018 09:12AM Applied DNA and Eurofins BLC Sign Collaboration Agreement to Support Commercial Implementation of Leather Traceability System
Nov 5, 2018 08:30AM New Study: DNA Molecular Tagging is an Effective Tool to Authenticate Denim, One of the Toughest Fabrics
Oct 29, 2018 05:00AM GHCL, a Global Home Textiles Player, Creates “CIRKULARITY”, a Brand Platform, Inspired By “REKOOP” Sustainable, Traceable, Recycled Polyester Bedding
Oct 24, 2018 05:00AM Applied DNA Enters FY2019 with Strong Business Momentum
Oct 16, 2018 05:00AM Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-Viral, Plasmid-Free CAR T Manufacturing Platform
Oct 4, 2018 05:00AM Applied DNA Appoints Industry Veteran Wayne Buchen Vice President of Strategic Sales for Textile Vertical
Oct 1, 2018 05:00AM LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
Sep 25, 2018 05:00AM Applied DNA Expands Cannabis Tagging Portfolio to Address Large Growers
Sep 20, 2018 05:00AM Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
Sep 18, 2018 07:14AM Applied DNA Forms Wholly Owned Subsidiary, LineaRx, to Develop Large-Scale, PCR-Produced DNA for Biotherapeutics
View More Recent Stories View Older Stories